Saturday, April 1, 2023 |
9:30 - 11:45 AM | Salon 8 |
What's New Since Our Last Conference |
Chair(s): Andrea Van Beek |
9:30 |
Welcome & Thank You For Joining Us! |
9:53 |
Anticoagulation Stewardship University of NM |
10:14 |
Top Papers You Need To Know |
10:14 |
Top Papers You Need To Know UCSF |
10:57 |
New Agents, New Indications McMaster University |
11:22 |
Q&A Panel |
11:42 |
Pre-Case (Special Situations) |
12:00 - 1:00 PM | Salon 1-4 |
Expert Perspectives on the Treatment of DVT/PE and Reduction in the Risk of Recurrent DVT/PE, With a Focus on DVT/PE Patients With Obesity and/or Cancer (Sponsored by Janssen Pharmaceuticals, Inc) |
Distinguished faculty will provide expert perspectives on the treatment of DVT/PE and reduction in the risk of recurrent DVT/PE in patients at continued risk for recurrent DVT and/or PE. In addition, they will discuss the treatment of and reduction in the risk of recurrent DVT/PE in patients with obesity and/or cancer.
Faculty: Parth Rali, MD, Jerrica Waggoner, PharmD, BCPS, BCCP, James Williams, MS, DO, FACEP |
1:15 - 3:25 PM | Salon 8 |
Special Situations |
Chair(s): Anita Rajasekhar |
1:15 |
Warfarin Management VA Sierra Nevada Healthcare System |
1:38 |
Cancer And Vte Ottawa Hospital Research Institute |
2:02 |
Women'S Health University of Utah Health |
2:27 |
Clinic Administration Visalia Medical Clinic |
2:54 |
Q&A |
2:54 |
Post-Case |
3:20 |
Pre-Case (The Vasculopathic Patient) |
3:25 - 3:45 PM | Salon 7 |
Break |
3:45 - 5:30 PM | Salon 8 |
The Vasculopathic Patient |
Chair(s): Geoffrey Barnes |
3:45 |
Treatment Strategies For Pad Dignity Health Medical Group |
4:25 |
Speciality Perspective: Neurologist UCSF |
4:58 |
Speciality Pespective: Vascular Surgeon University of California San Francisco / San Francisco VA |
5:27 |
Post-Case |
5:27 |
Q&A |
5:27 |
Pre-Case (Starting & Stopping Anticoagulation) |
5:30 - 6:30 PM | Salon 7 |
Poster Session/Welcome Reception & 10th Anniversary of Centers of Excellence |
P10 |
Impact Of Pharmacist Led Anticoagulation Clinic In Cardiac Specialized Hospital National Institute of Cardiovascular Diseases, Karachi, Pakistan |
P20 |
Maximizing The Clinical Pharmacy Technician Role Within A Centralized Anticoagulation Services Hub At The Veterans Health Administration VA Great Lakes Health Care System, Westchester, IL, United States |
P30 |
Assessment Of Pharmacists&Rsquo; Intervention In The Initiation Of A Direct Oral Anticoagulant (Doac) Dashboard: Initial Phase Michigan Medicine, Ann Arbor, MI, United States |
P40 |
Multidisciplinary Approach In The Initiation Of A Direct Oral Anticoagulant (Doac) Dashboard Michigan Medicine, Ann Arbor, MI, United States |
P50 |
Warfarin-Rifampin Drug-Drug-Gene Interaction (Warif-G) 1Clinical Pharmacy Department, Hamad Medical Corporation, Doha, Qatar, 2College of Pharmacy, QU Health, Qatar University , Doha, Qatar, 3Biomedical and Pharmaceutical Research Unit, Doha, Qatar |
P60 |
Protocolized Critical Inr Management In A Pharmacist-Led Anticoagulation Clinic 1UW Health , Madison, WI, United States, 2University of Wisconsin-Madison School of Pharmacy, Madison, WI, United States |
P70 |
Barriers And Facilitators To Warfarin Patient Self-Management In The Us Healthcare System 1University of Utah College of Pharmacy, Salt Lake City, UT, United States, 2University of Utah Office of Research Integrity and Compliance, Salt Lake City, UT, United States, 3University of Utah Health, Salt Lake City, UT, United States, 4University of Michigan, Ann Arbor, MI, United States, 5Brigham and Women�s Hospital, Boston, MA, United States, 6VA Loma Linda Healthcare System, Loma Linda, CA, United States, 7VA Eastern Colorado Health Care System, Aurora, CO, United States, 8University of Utah School of Medicine, Salt Lake City, UT, United States |
P80 |
EValuating The Process Of TRansitionIng Atrial Fibrillation (Af) Patients From WArfarin To A Direct ORal ANticoagulant (Doac) IN A�PHarmacist-Led ANticoagulation CLinic� UC Davis Health, Sacramento, CA, United States |
P90 |
Anticoagulant Management Of Covid-19 Patients With Thrombotic Complications� 1Global Thrombosis Forum, Suwanee, GA, United States, 2Loyola University , Chicago, IL, United States |
P100 |
Clinical And Genetic-Based Refinement Of The Warfarin Dose 1Department of Medicine, Washington University in St. Louis, Saint Louis, MO, United States, 2Department of Health and Clinical Outcomes Research, Saint Louis University, Saint Louis, MO, United States, 3Department of Computer Science, Saint Louis University, Saint Louis, MO, United States, 4Department of Medicine, Hospital for Special Surgery/Weill Cornell Medicine, New York, New York, NY, United States, 5Department of Pathology and Immunology, Washington University in St. Louis, Saint Louis, MO, United States |
P110 |
Biomarkers Of Hemostatic Dysregulation� 1Global Thrombosis Forum, Suwanee, GA, United States, 2Loyola University, Chicago, IL, United States |
P120 |
Utilization Of A Direct Oral Anticoagulant Population Management Tool: Standardizing Assessment Of Hemoglobin Flags 1Minneapolis VA Health Care System, Minneapolis, MN, United States, 2VA Salt Lake City Health Care System, Salt Lake City, UT, United States |
P130 |
Warfarin Use Is Associated With Higher Rates Of Clinically Relevant Epistaxis Compared To Direct Oral Anticoagulants 1Central Michigan University College of Medicine, Mount Pleasant, MI, United States, 2Michigan Medicine, Ann arbor, MI, United States, 3Beaumont Health System, Royal Oak, MI, United States, 4Division of Hospital Medicine, Henry Ford Hospital, Detroit, MI, United States |
P140 |
Prevalence And Predictors Of Underdosing In Patients Initiating Direct Oral Anticoagulants For Atrial Fibrillation Or Venous Thromboembolism 1Frankel Cardiovascular Center-University of Michigan Medicine Health, Ann Arbor, MI, United States, 2William Beaumont Hospital, Royal Oak, MI, United States, 3Henry Ford Hospital-Division of Hospital Medicine, Detroit, MI, United States |
P150 |
Characterization Of Direct-Acting Oral Anticoagulants (Doac) Dosing: �A Cross-Sectional Real-World Evaluation Of Us Patients With Non-Valvular Atrial Fibrillation Pfizer Inc., New York, NY, United States |
P160 |
Procedural/Surgical Rhythm Control For Patients With Atrial Fibrillation: A Meta-Analysis Washington University School of Medicine, St. Louis, MO, United States |
P170 |
Eligibility And Discussions Of Left Atrial Appendage Occlusion In Patients On Anticoagulation For Atrial Fibrillation University of Michigan Health, Frankel Cardiovasclar Center, Ann Arbor, MI, United States |
P180 |
Thrombogenicity Of An Implantable Cardioverter Defibrillator Lead Beats Anticoagulation: A Case Report University Hospitals of Cleveland Medical Center, Cleveland, OH, United States |
P190 |
Sars-Cov-2 Infection And The Management Of Long-Term Warfarin Therapy 1Mayo Clinic Health System, La Crosse, WI, United States, 2Mayo Clinic Health System, Mankato, MN, United States, 3Mayo Clinic , Rochester, MN, United States, 4Mayo Clinic Health System, Owatonna , MN, United States |
P200 |
A Population Health Approach To Stroke Prevention In Atrial Fibrillation/Flutter: Targeting The Untreated While Prioritizing Health Disparities 1VA Salt Lake City Health Care System, Salt Lake City, UT, United States, 2Veterans Integrated Service Network 8, St. Petersburg, FL, United States, 3Veterans Integrated Service Network 20, Vancouver, WA, United States |
P210 |
Community-Based�Antithrombotic Stewardship To Combat Health Disparities In Peripheral Artery Disease Oklahoma State University Center of Health Sciences, Tulsa, OK, United States |
P220 |
Scoping Review: Racial Disparities In Anticoagulation Care Delivery (Interim Data) 1University of Utah Health , 2Kaiser Permanente , 3University of Kentucky College of Pharmacy, 4Anticoagulation Forum , 5University of Utah Eccles Health Sciences Library |
P230 |
A Comparison Of Antifactor Xa (Afxa) Nomograms And Activated Partial Thrombin Time (Aptt) Nomograms For Nurse Driven Systemic Unfractionated Heparin (Ufh) Infusions Community Medical Centers, Fresno, CA, United States |
P240 |
Improving The Diagnosis And Management Of Heparin Induced Thrombocytopenia (Hit) With Electronic Consultation 1Division of Hematology/Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States, 2Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL, United States, 3Department of Pharmacy, University of Alabama at Birmingham, Birmingham, AL, United States, 4Clinical Informatics, University of Alabama at Birmingham, Birmingham, AL, United States, 5Special Coagulation Service, University of Alabama at Birmingham, Birmingham, AL, United States, 6Division of Laboratory Medicine, Department of Pathology, University of Alabama at Birmingham, Birmingham, AL, United States |
P250 |
Potential Drug-Drug Interactions With Anticoagulants Among Post-Operated Patients Of A Tertiary Cardiac Care Institute In Pakistan 1National Institute of Cardiovascular Diseases (NICVD), Karachi, Pakistan, 2Sindh Institute of Management & Technology (SMIT), Karachi, Pakistan, 3Department of Pharmacology, University of Karachi, Karachi, Pakistan |
P260 |
Assessing The Implication Of Increased Bleeding Risk Associated With Concurrent Use Of Rivaroxaban And Dual P-Gp Inhibitor And Moderate Cyp3A4 Inhibitors. 1The Johns Hopkins Hospital, Baltimore, MD, United States, 2Notre Dame of Maryland University, Baltimore, MD, United States |
P270 |
Identification Of Incorrect Dosing Of Direct Oral Anticoagulants By Ward Pharmacists: A Multidisciplinary Approach To Improve Patient Safety � Pharmacy Department of the University Hospital Vienna, Vienna, Austria |
P280 |
Leveraging Learners In The Education Of Anticoagulated Patients - The Leap Feasibility Pilot Study 1Georgetown University School of Medicine, Washington, DC, United States, 2MedStar Georgetown University Hospital, Washington, DC, United States, 3University of Maryland School of Pharmacy, Baltimore, MD, United States |
P290 |
Homogeneous Enzyme Immunoassay For The Determination Of Rivaroxaban In Human Plasma ARK Diagnostics, Fremont, CA, United States |
P300 |
Inr Management In Antiphospholipid Syndrome Patient With Type Ii Secondary Arteriovenous Fistula The Ohio State University, Columbus, OH, United States |
P310 |
Homogeneous Enzyme Immunoassay For The Determination Of Apixaban In Human Plasma ARK Diagnostics, Fremont, CA, United States |
P320 |
A Case Of Persistently Subtherapeutic�Antifactor Xa (Afxa) Levels Despite�Heparin Infusion Dose Uptitration In A Patient With Left Ventricular Assist Device (Lvad) Community Medical Centers, Fresno, CA, United States |
P330 |
Outcomes Of Warfarin Home Inr Monitoring Vs Office-Based Monitoring: A Retrospective Claims-Based Analysis 1Visalia Medical Clinic, Visalia, CA, United States, 2VA Eastern Colorado Health Care System, Aurora, CO, United States, 3San Francisco VA Health Care System, San Francisco, CA, United States, 4University of California - San Francisco, Department of Medicine, San Francisco, CA, United States, 5Genesis Research, Hoboken, NJ, United States, 6University at Albany - SUNY, Albany, NY, United States, 7Hofstra Northwell Zucker School of Medicine, Hempstead, NY, United States |
P340 |
Impact Of Electronic Transmission Of Patient Pt/Inr Home Self-Testing Results 1Orthodynamics Company, Inc. (ODI), Noblesville, IN, United States, 2CoaguSense, Inc., Fremont, CA, United States, 3Stel, Life, Inc. , Philadelphia, PA, United States |
P350 |
A Comparison Of Historical Bridging Practices Within A Single Center With Recommendations Found In The 2022 Updated Enoxaparin Bridging Guidelines For Patients On Warfarin And An Evaluation Of Bleeding Rate 1University of Wisconsin-Madison (UW) Northern Illinois, Rockford, IL, United States, 2University of Illinois Chicago , Chicago, IL, United States |
P360 |
2021 Encore: Successful Adaptation Of The Management Of Anticoagulation In The Peri-Procedural Period (Mappp) Active Clinical Decision Support Into A Nurse-Driven Protocol 1Oklahoma State University Center for Health Sciences, Tulsa, OK, United States, 2Bassett Healthcare Network, Cooperstown, NY, United States |
P370 |
Operationalizing Standardized Periprocedural Anticoagulation Management: A Stewardship Initiative 1Oklahoma State University Center for Health Sciences, Tulsa, OK, United States, 2Bassett Healthcare Network, Cooperstown, NY, United States, 3The Anticoagulation Forum, Newton, MA, United States |
P380 |
Perioperative Management Of Direct Oral Anticoagulants And Antiplatelet Therapy For Gastrointestinal Procedures� � Lahey Hospital and Medical Center, Burlington, MA, United States |
P390 |
What&Rsquo;S Stopping You: Impact Of Anticoagulation On Procedural Delays And Cancellations At An Academic Safety Net Hospital.� 1Morehouse School of Medicine, Atlanta, GA, United States, 2Grady Memorial Hospital, Atlanta, GA, United States, 3Emory University Department of Medicine, Atlanta, GA, United States |
P400 |
�Development Of Clinical Pharmacist Led Anticoagulation Stewardship Program In Cardiac Care Setting In Developing Country. 1Tabba Heart Institute, KARACHI, Pakistan, 2Tabba Heart Institute, KARACHI, Pakistan, 3Tabba Heart Institute, KARACHI, Pakistan, 4Tabba Heart Institute, KARACHI, Pakistan |
P410 |
External Validation Of Published Heparin Population Pharmacokinetic Models For Model-Informed Precision Dosing 1InsightRX, San Francisco, CA, United States, 2Novant Health, Charlotte, NC, United States |
P420 |
Co-Prescribing Of Antiplatelets With Direct Oral Anticoagulants: A Medication Safety Initiative 1Veterans Health Administration VISN 8 Pharmacy Benefits Management, Bay Pines, FL, United States, 2University of Minnesota, College of Pharmacy, Minneapolis, MN, United States, 3University of Michigan , Ann Arbor, MI, United States, 4Veterans Affairs Center for Clinical Management Research, Ann Arbor, MI, United States, 5North Florida South Georgia Veterans Health Care System, Gainesville, DC, United States, 6Caribbean Veterans Affairs Health Care System, San Juan, PR, United States, 7Tamp Bay Veterans Affairs Health Care System, Tampa Bay, FL, United States, 8Miami Veterans Affairs Health Care System, Miami, FL, United States, 9West Palm Beach Veterans Affairs Health Care System, West Palm Beach, FL, United States, 10Bay Pines Veterans Affairs Health Care System, Bay Pines, FL, United States, 11Orlando Veterans Affairs Health Care System, Orlando, FL, United States, 12Veterans Health Administration Pharmacy Benefits Management VA MedSAFE, Washington, DC, United States |
P430 |
Implementation Of A Comprehensive Perioperative Anticoagulation Management Program Leveraging The Electronic Health Record At An Academic Medical Center West Virginia University (WVU) Medicine, Morgantown, WV, United States |
P440 |
Anti-Xa Target Attainment & Dose Selection: Comparison Of Pharmacokinetic Model-Guided Dosing Versus Institutional Practice 1InsightRX, San Francisco, CA, United States, 2Novant Health, Charlotte, NC, United States |
P450 |
Evaluating The Prevalence Of Osteopenia Or Osteoporosis In Veterans On Long-Term Warfarin Therapy VA Sierra Nevada Healthcare System, Reno, NV, United States |
P460 |
Antithrombosis Stewardship Within A Veterans Affairs Health System: Review Of Combined Oral Anticoagulants And Antiplatelets� 1VA Sierra Nevada Health Care System, Reno, NV, United States, 2VA Durham Health Care System, Durham, NC, United States, 3Magellan Rx, Phoenix, AZ, United States |
P470 |
Direct Oral Anticoagulants: An In-Depth Look At Harmful Events Reported To Ecri And The Ismp Patient Safety Organization 1Institute for Safe Medication Practices, Plymouth Meeting, PA, United States, 2ECRI, Plymouth Meeting, PA, United States |
P480 |
2021 Encore:�National Board Certification As An Anticoagulation Care Provider: Barriers, Motivators And New Cacp Recertification Processes 1Oklahoma State University Center for Health Sciences, Tulsa, OK, United States, 2National Certification Board of Anticoagulation Care Providers, Chicago, IL, United States, 3Massachusetts General Anticoagulation Management Service, retired, Boston, MA, United States, 44University of Southern Indiana College of Nursing and Health Professions, Evansville, IN, United States |
P490 |
Antiplatelet De-Escalation In Patients Receiving Oral Anticoagulants:� Less Is More 1Clinical Pharmacy Specialist-Cardiology, Veterans Affairs Caribbean Healthcare System,, San Juan, PR, United States, 2Clinical Pharmacist Specialist-Anticoagulation, Veterans Affairs Caribbean Healthcare System, San Juan, PR, United States, 3Pharmacy PGY1 Resident 2021-2022, Veterans Affairs Caribbean Healthcare System, San Juan, PR, United States |
P500 |
Safe Timely Resumption Of Pharmacologic Thromboembolism Prevention In Hospitalized Patients With A Recent Major Bleed University of New Mexico Health Sciences Center, Albuquerque, NM, United States |
P510 |
Aspirin Deprescribing In Patients On Oral Anticoagulation For Atrial Fibrillation Or Venous Thromboembolism: A National Survey Of Clinician Practices 1Department of Pharmacy Practice, College of Pharmacy, University of Illinois at Chicago, Chicago, IL, United States, 2Division of Epidemiology and Biostatistics, School of Public Health, University of Illinois at Chicago, Chicago, IL, United States |
P520 |
The Challenges Of Patient Activation: A Pilot Factorial Trial Examining Multilevel Interventions To Reduce Bleeding Risk In Patients Prescribed Combination Antithrombotic Therapy 1Department of Internal Medicine, University of Michigan, Ann Arbor, MI, United States, 2Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor, MI, United States, 3Veterans Affairs (VA) Ann Arbor Center for Clinical Management Research, Ann Arbor, MI, United States, 4Frankel Cardiovascular Center, Department of Internal Medicine, University of Michigan, Ann Arbor, MI, United States, 5Department of Family Medicine, Brown University , Providence, RI, United States, 6Department of Biostatistics, University of Michigan School of Public Health, Ann Arbor, MI, United States, 7Department of Learning Health Sciences, University of Michigan, Ann Arbor, MI, United States, 8Department of Gynecology and Obstetrics, University of Michigan, Ann Arbor, MI, United States, 9University of Michigan Office of Clinical Informatics, Ann Arbor, MI, United States, 10Health Information Technology and Services, University of Michigan, Ann Arbor, MI, United States, 11Center for Bioethics and Social Sciences in Medicine, University of Michigan, Ann Arbor, MI, United States |
P530 |
The Nationwide Implementation Of A Population Management Dashboard For Monitoring Direct Oral Anticoagulants: Insights From The Veterans Affairs Health System 1College of Pharmacy, University of Michigan, Ann Arbor, MI, United States, 2Frankel Cardiovascular Center, University of Michigan, Ann Arbor, MI, United States, 3Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor, MI, United States, 4Ann Arbor Veterans Health Affairs, Ann Arboor, MI, United States, 5Veterans Affairs Salt Lake City Health Care System , Salt Lake City, UT, United States, 6School of Nursing, University of Missouri,, Columbia, MO, United States, 7Michigan Medicine - Center for Bioethics and Social Science in Medicine, University of Michigan, Ann Arbor, MI, United States, 8VISN 20 Network Office, Veterans Health Affairs, Vancouver, WA, United States |
P540 |
The Utility Of An Inr And Best Practice For Monitoring Doac Therapy�� 1West Virginia University Medicine, Morgantown, WV, United States, 2West Virginia University School of Pharmacy, Morgantown, WV, United States |
P550 |
Patient Compliance With Aspirin And Rivaroxaban Post Elective Joint Replacement Surgery: A Quality Assurance Initiative 1St. Joseph's Healthcare Hamilton, Hamilton, ON, Canada, 2McMaster University, Faculty of Nursing, Hamilton, ON, Canada |
P560 |
Measuring The Impact Of Va Text Reminder Messages For Patients Taking Direct Oral Anticoagulants Department of Veteran Affairs Pacific Islands Health Care System, Honolulu, HI, United States |
P570 |
Medication Use Evaluation: Cangrelor For Percutaneous Coronary Intervention And Bridging Bryan Medical Center, Lincoln, NE, United States |
P580 |
� Cancer Associated Thrombosis: Optimizing The Prevention And Treatment In High Risk Cancer Patients University Health Network, Toronto, ON, Canada |
P590 |
Impact Of Clinical Pharmacy Services On Direct Oral Anticoagulant Medication Selection And Dosing In The Ambulatory Care Setting Kaiser Permanente, Atlanta, GA, United States |
P600 |
Continuum Of Stewardship: Oversight And Continual Process Improvement Of A Population Management Tool In Veterans Health Administration 1VA Salt Lake City Health Care System , Salt Lake City , UT, United States, 2Veterans Health Administration VISN 8 Pharmacy Benefits Management, Bay Pines, FL, United States, 3University of Minnesota, College of Pharmacy, Minneapolis , MN, United States, 4Veterans Health Administration Pharmacy Benefits Management VA MedSAFE, Washington, DC, United States, 5Veterans Affairs Center for Medication Safety/Pharmacy Benefits Management Services, Hines, IL, United States, 6Veterans Health Administration Northwest Health Network, Vancouver, WA, United States |
P610 |
Defining Success In Anticoagulation Stewardship: The Development Of Doac Population Health Management Quality Reports In Veterans Health Administration 1VA Salt Lake City Health Care System, Salt Lake City, UT, United States, 2Veterans Health Administration Pharmacy Benefits Management VA MedSAFE, Washington, DC, United States, 3VA Salt Lake City Health Care System, Salt Lake City, UT, United States, 4VA Salt Lake City Health Care System, Salt Lake City, UT, United States |
P620 |
The Effect Of A Multi-Healthcare Organization Quality Improvement Project On Aspirin Deprescribing 1Henry Ford Health, Detroit, MI, United States, 2University of Michigan Medical Center, Ann Arbor, MI, United States, 3Bassett Health, Cooperstown , NY, United States, 4Froedtert Hospital, Milwaukee, WI, United States, 5Lahey Hospital and Medical Center, Burlington, MA, United States, 6Mercy Health, Grand Rapids, MI, United States, 7Mercy Health St. Anne Hospital, Toledo, OH, United States, 8Mercy Health St. Charles Hospital, Oregon , OH, United States, 9Mission Hospital, Asheville, NC, United States, 10Stanford Health Care and Clinics, Palo Alto, CA, United States, 11University of Illinois, Chicago, IL, United States, 12University of Colorado Health Heart and Vascular Clinic, Steamboat Springs, CO, United States, 13University of Wisconsin Medical Center, Madison, WI, United States, 14VA Sierra Nevada Health Care System, Reno, NV, United States, 15Waldo County General Hospital Anticoagulation Clinic, Belfast , ME, United States, 16University of Utah Health, Sandy , UT, United States |
P630 |
Providers\' Perception Of The Impact Of Covid-19 On Warfarin Therapy Management university of Utah, Salt Lake City, UT, United States |
P640 |
Improving The Understanding Of Population Health-Based Digital Tools For Anticoagulation Management 1University of Utah College of Pharmacy, Salt Lake City, UT, United States, 2Anticoagulation Forum, Newton, MA, United States, 3VA Salt Lake City Health Care System, Salt Lake City, UT, United States, 4University of New Mexico Health Sciences Center, Albuquerque, NM, United States, 5Pfizer Inc., New York City, NY, United States, 6Frankel Cardiovascular Center, University of Michigan, Ann Arbor, MI, United States |
P650 |
Low Dose Prothrombin Complex Concentrate For Direct Oral Anticoagulant Reversal� 1University of Wisconsin-Madison, School of Pharmacy, Madison, WI, United States, 2University of Wisconsin Health, Madison, WI, United States |
P660 |
The Use Of Andexanet Alfa Vs. Four Factor Prothrombin Complex Concentrates In The Reversal Of Life-Threatening Intracranial Hemorrhage 1University of Florida, Gainesville, FL, United States, 2Moffitt Cancer Center, Tampa Bay, FL, United States |
P670 |
A Case Of Dabigatran Accumulation With Hemorrhage And Coagulopathy� 1Hematology Consult Section, Division of Intramural Research, National Heart Lung Blood Institute, Bethesda, MD, United States, 2National Cancer Institute, Bethesda, MD, United States, 3Hematology Section, Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, MD, United States, 4Surgery Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, United States, 5Surgery Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, United States, 6Hematology Consult Section, Division of Intramural Research, National Heart Lung Blood Institute, Bethesda, MD, United States |
P680 |
Vascular Thrombosis In Antiphospholipid Syndrome Patient Despite Appropriate Anticoagulation Therapy 1Howard University College of Pharmacy, Washington,, DC, United States, 2Howard University Hospital, Washington,, DC, United States |
P690 |
Using Anti-Xa Monitoring To Manage Anticoagulation For Mechanical Heart Valves During Pregnancy University of California, San Francisco, San Francisco, CA, United States |
P710 |
Evaluation Of Apixaban Anti-Xa Activity, Efficacy, And Safety Post-Bariatric Surgery 1University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, CO, United States, 2University of Colorado Hospital, Aurora, CO, United States |
P720 |
Pharmacist-Led, Checklist Driven Care Did Not Improve Adherence In Ambulatory Patients Starting Or Resuming A Direct Oral Anticoagulant After Setback&Ndash; The Leave Safe With Doacs Study UMass Chan Medical School, Worcester, MA, United States |
P730 |
2021 Encore:�Operationalizing Efficient And Effectiveness Anticoagulation-Related Discharge Communication 1Oklahoma State University Center for Health Sciences, Tulsa, OK, United States, 2Bassett Healthcare Network, Cooperstown, NY, United States |
P740 |
Insurance Adjudication Of Anticoagulants Prior To Discharge - Results From A Pilot Study 1Georgetown University School of Medicine, Washington, DC, United States, 2MedStar Georgetown University Hospital, Washington, DC, United States, 3University of Maryland School of Pharmacy, Baltimore, MD, United States |
P750 |
Establishment And Utilization Of An Advanced Practice Provider-Led Clinic For Newly Diagnosed Venous Thromboembolism University of North Carolina, Chapel Hill, Chapel Hill, NC, United States |
P760 |
Impact Of Cancer On Outcome Among Hospitalized Patients With Venous Thromboembolism: Data From National Inpatient Sample 1Thomas Jefferson University Hospital , Philadelphia, PA, United States, 2Reading Hospital, West Reading, PA, United States |
P770 |
Anticoagulation (Ac) Clinical Pharmacy Practitioners (Cpps) Utilization Of Direct Oral Anticoagulant (Doac) Starter Packs In The Ambulatory Care Setting For Outpatient Treatment Of Acute, Stable Deep Vein Thrombosis (Dvt) VA North Texas Health Care System, Dallas, TX, United States |
P780 |
Direct Oral Anticoagulants For The Treatment Of Splanchnic Vein Thrombosis - A Systematic Review And Meta-Analysis 1The Ottawa Hospital Research Institute, The Ottawa Hospital, Ottawa, ON, Canada, 2Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada, 3Michael G. DeGroote School of Medicine, Hamilton, ON, Canada, 4Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada, 5Department of Medicine, McMaster University, Hamilton, ON, Canada, 6Department of Medicine, University of Ottawa, Ottawa, ON, Canada |
P790 |
Thromboembolism Risk And Management Pattern In Hospitalized Covid-19 Patients: A Single-Center Experience In Ethiopia Addis Ababa University, Addis Ababa, Ethiopia |
P800 |
Attributes Of Randomized Controlled Trials And Their Associations With Funding Source In Venous Thromboembolism Prophylaxis For Patients With Cancer: A Bibliographical Analysis 1Faculty of Health Sciences, McMaster University, Hamilton, ON, Canada, 2Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada, 3Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada, 4Department of Medicine, McMaster University, Hamilton, ON, Canada |
P810 |
Inferior Vena Cava Filter Use At A Large Community Hospital: A Cross-Sectional Analysis 1Schulich School of Medicine and Dentistry, London, ON, Canada, 2Department of Medical Oncology, Windsor Regional Cancer Centre, Windsor, ON, Canada |
P820 |
Significance Of The Loading Phase Duration Of Apixaban On Bleeding Events In Patients Treated For Newly Diagnosed Venous Thromboembolism After Initial Parenteral Anticoagulation Treatment Memphis VA Medical Center, Memphis, TN, United States |
6:30 - 7:30 PM | Salon 1-4 |
Outcomes of Patient Self-Testing for Warfarin Therapy: Key Findings from Retrospective Studies (Sponsored by Acelis Connected Health) |
Session will highlight findings from two retrospective studies on patient self-testing for warfarin therapy. The first study looked at virtual versus in-person education for PST for warfarin therapy, showing that virtual education is effective and should continue to be an option. The second study was a retrospective claims-based analysis looking at clinical outcomes of home INR testing (patient self-testing or PST). The study showed lower rates of adverse events including deep venous thrombosis, pulmonary embolism, bleeding, and stroke as well as fewer emergency department visits among self-testing patients versus those who had office/lab-based monitoring.
Please register to attend the session here: https://fs10.formsite.com/spltrak/miheypirhv/index Note: Registration is not required to attend, but is highly recommended. Priority to attend will be given to those that pre-register for the session. |
Sunday, April 2, 2023 |
7:45 - 8:15 AM | Salon 7 |
Continental Breakfast |
8:15 - 10:25 AM | Salon 8 |
Red Light, Green Light: Starting & Stopping Anticoagulation |
Chair(s): Allison Burnett |
8:15 |
Understanding Doac Reversal University of Ottawa/Ottawa Hospital Research Institute |
8:43 |
Effective Utilization Of Periprocedural Anticoagulation VA Eastern Colorado Health Care System |
9:09 |
Speciality Perspective: Neurosurgeon Tallahassee Neurological Clinic / Tallahassee Memorial Healthcare / FSU |
9:37 |
Speciality Perspective: Gastroenterologist University of Michigan |
10:04 |
Post-Case |
10:04 |
Q&A |
10:24 |
Pre-Case (The Heart Of It All) |
10:25 - 10:45 AM | Salon 7 |
Break |
10:45 - 12:30 PM | Salon 8 |
The Heart of it All |
Chair(s): Bill Dager |
10:45 |
Laao Devices Overview: What, When, Who, And How Versiti |
11:06 |
Tracking The Heart: Af Detection, Loop Recorders, & Event Monitors San Francisco VA / UCSF |
11:32 |
An Overview Of Lv Thrombus University of Michigan |
11:56 |
Post-Case |
11:56 |
Q&A |
11:56 |
Pre-Case (Diagnostic & Prognostic Dilemmas) |
12:45 - 1:45 PM | Salon 1-4 |
Anticoagulation Reversal: Real-World Data Matters, Too (Sponsored by AstraZeneca Pharmaceuticals) |
Introduction and assessment of real-world data (RWD) is critically important for FXa inhibitor-related bleeds in treatment-emergent situations, particularly since this crucial information has been limited to date within a complex clinical landscape. Join experts to explore how reversal agents can manage life-threatening bleeds in the presence of anticoagulation and learn how the latest published RWD guide reversal and repletion strategies in anticoagulated patients.
In support of improving patient care, this activity has been planned and implemented by Global Learning Collaborative (GLC) and TotalCME, Inc. GLC is jointly accredited by the American Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE) and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. This activity was planned by and for the healthcare team, and learners will receive 1.0 Interprofessional Continuing Education (IPCE) credits for learning and change. Please register to attend the session here: https://www.mededonthego.com/ACRWD Note: Registration is not required to attend, but is highly recommended. Priority to attend will be given to those that pre-register for the session. |
2:00 - 4:05 PM | Salon 8 |
Diagnostic & Prognostic Dilemmas |
Chair(s): Scott Kaatz |
2:00 |
D-Dimer, Doac Levels And Other Laboratory Dilemmas Associate Professor, Laboratory Medicine and Medicine, University of Toronto |
2:35 |
Diagnosing And Prognostic Models For Vte University of Pennsylvania |
2:49 |
Thrombophilia Testing And Management University of North Carolina School of Medicine |
3:16 |
Addressing Anticoagulation Failure University of Florida |
3:43 |
Post Case |
3:45 |
Q&A |
4:05 - 4:25 PM | Salon 7 |
Break |
4:25 - 5:45 PM | Salon 8 |
Asked & Answered Rapid Fire |
Topics:
|
Chair(s): Arthur Allen |
4:25 |
Panelists |
Monday, April 3, 2023 |
8:15 - 9:00 AM | Salon 1-4 |
Meet the Expert Breakfast |
8:45 - 9:15 AM | Salon 7 |
Continental Breakfast |
9:15 - 11:15 AM | Salon 8 |
Crazy Clotting |
Chair(s): Mark Crowther |
9:15 |
Location, Location, Location Intermountain Medical Center |
9:36 |
Antiphospholipid Syndrome University of Washington |
9:58 |
Hit & Vitt McMaster University |
10:19 |
Arterial Thrombosis University of Alabama at Birmingham |
10:38 |
Pediatric Clotting Hospital for Sick Children |
10:58 |
Q&A |
11:15 - 12:15 PM | Salon 8 |
President's Panel - Difficult Cases |
Chair(s): Geoffrey Barnes |
11:15 |
Panelist |
11:15 |
Panelist Univ of Washington |
11:15 |
Panelist Henry Ford Health |
11:15 |
Panelists |
12:15 - 12:30 PM | Salon 8 |
Wrap Up & Closing |